ExpreS2ion Biotech Holding AB's market cap is currently €5.04M. The company's EPS TTM is €-0.342998847; its P/E ratio is ―; ExpreS2ion Biotech Holding AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
ExpreS2ion Biotech Holding AB Earnings and Revenue History
